What should investors do with Natural Capsules?

What should investors do with Natural Capsules?

by 5paisa Research Team Last Updated: Apr 20, 2023 - 01:09 pm 261 Views

Smallcap companies come with high risk but present investors with unlimited upside potential. 

Growth and profitability are key components in analysing a Smallcap stock, along with industry in which it pertains. One such company that has exhibited strong growth phase along with improvement in financial numbers is Natural Capsules (BSE Code - 524654), and has jumped nearly 10 per cent on Thursday, April 20. 

Company profile 

Natural Capsules is a Rs 450 crore pharmaceutical company that specializes in the manufacturing and distribution of empty hard gelatine capsules, pharmaceutical formulations, and dietary supplements. The company was founded in 1993 and has since grown to become a leading supplier of empty capsules in India and several other countries. The company's product portfolio includes a wide range of capsules, including transparent capsules, coloured capsules, vegetarian capsules, and enteric capsules. 

The company holds strong capex plans and has recently invested in its subsidiary Natural Biogenex having a Rs 115 crore capex. 

Quarterly performance 

In its Q3FY23, the company reported net sales at Rs 45.50 crore, which is nearly 21% YoY rise from the corresponding quarter of the previous financial year. Moreover, net profit jumped 28% YoY to Rs 5.25 crore from Rs 4.10 crore in December 2021. The management expects the robust growth phase to continue with an improvement in margins.

Technical analysis  

Technically, the stock has broken out from its 13-week consolidation phase and trades above all its key moving averages. Interestingly, it has also retraced about 32.80% retracement level from its prior downtrend. Renew buying interest in the stock is evident from above average volumes. The other technical parameters also show strong strength in the momentum. 

In a nutshell, the stock with such strong financial caliber and bullish technical setup is likely to attract investors. Long term investors focusing on growth should keep a track of this stock in upcoming trading sessions.

How do you rate this article?


Start Investing in 5 mins*

Rs. 20 Flat Per Order | 0% Brokerage

About the Author

Our research team is composed of some highly qualified research professionals, their expertise range across sectors.


Investment/Trading in securities Market is subject to market risk, past performance is not a guarantee of future performance. The risk of loss in trading and investment in Securities markets including Equites and Derivatives can be substantial. Also, The

Open Free Demat Account

Resend OTP
Please Enter OTP
Account belongs to

By proceeding, you agree to the T&C.

Latest News
Sahana Systems IPO GMP (Grey Market Premium)

Sahana Systems IPO worth ₹32.74 crore comprises entirely of a fresh issue of shares by the company. The price band has been fixed in the range of ₹132 to ₹135.

  • Jun 08, 2023
Infollion Research Services has bumper listing at 155% premium

Infollion Research Services Ltd had a bumper listing on 08th June 2023, listing at a sharp premium of 154.88%, but subsequently gave up some of the bumper gains towards the close of trade as the markets also wobbled in the second half of the trading day.

  • Jun 08, 2023
Three Interesting NFOs expected in June

New fund offerings (NFOs) are a regular offering from the various mutual fund houses. In the last few months, the practice of companies tapping the Indian investors through NFOs has picked up once again.

  • Jun 08, 2023

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number